Omission of lymphadenectomy is possible for low-risk corpus cancer.
Identifieur interne : 002476 ( Ncbi/Merge ); précédent : 002475; suivant : 002477Omission of lymphadenectomy is possible for low-risk corpus cancer.
Auteurs : T. Hidaka [Japon] ; K. Kato ; R. Yonezawa ; T. Shima ; A. Nakashima ; K. Nagira ; T. Nakamura ; S. SaitoSource :
- European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [ 0748-7983 ] ; 2007.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Carcinome endométrioïde (), Carcinome endométrioïde (anatomopathologie), Carcinome endométrioïde (mortalité), Femelle, Humains, Lymphadénectomie (), Métastase lymphatique, Pronostic, Stade de la tumeur, Sujet âgé, Taux de survie, Tumeurs de l'endomètre (), Tumeurs de l'endomètre (anatomopathologie), Tumeurs de l'endomètre (mortalité), Études de suivi, Études rétrospectives.
- MESH :
- anatomopathologie : Carcinome endométrioïde, Tumeurs de l'endomètre.
- mortalité : Carcinome endométrioïde, Tumeurs de l'endomètre.
- Adulte, Adulte d'âge moyen, Carcinome endométrioïde, Femelle, Humains, Lymphadénectomie, Métastase lymphatique, Pronostic, Stade de la tumeur, Sujet âgé, Taux de survie, Tumeurs de l'endomètre, Études de suivi, Études rétrospectives.
English descriptors
- KwdEn :
- Adult, Aged, Carcinoma, Endometrioid (mortality), Carcinoma, Endometrioid (pathology), Carcinoma, Endometrioid (surgery), Endometrial Neoplasms (mortality), Endometrial Neoplasms (pathology), Endometrial Neoplasms (surgery), Female, Follow-Up Studies, Humans, Lymph Node Excision (contraindications), Lymphatic Metastasis, Middle Aged, Neoplasm Staging, Prognosis, Retrospective Studies, Survival Rate.
- MESH :
- contraindications : Lymph Node Excision.
- mortality : Carcinoma, Endometrioid, Endometrial Neoplasms.
- pathology : Carcinoma, Endometrioid, Endometrial Neoplasms.
- surgery : Carcinoma, Endometrioid, Endometrial Neoplasms.
- Adult, Aged, Female, Follow-Up Studies, Humans, Lymphatic Metastasis, Middle Aged, Neoplasm Staging, Prognosis, Retrospective Studies, Survival Rate.
Abstract
The objective of this study is to ascertain whether omission of lymphadenectomy is possible when endometrial cancer is considered low-risk based on intraoperative pathologic indicators.
DOI: 10.1016/j.ejso.2006.09.035
PubMed: 17095180
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003829
- to stream PubMed, to step Curation: 003829
- to stream PubMed, to step Checkpoint: 003829
Links to Exploration step
pubmed:17095180Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Omission of lymphadenectomy is possible for low-risk corpus cancer.</title><author><name sortKey="Hidaka, T" sort="Hidaka, T" uniqKey="Hidaka T" first="T" last="Hidaka">T. Hidaka</name><affiliation wicri:level="1"><nlm:affiliation>Department of Obstetrics and Gynecology, Faculty of Medicine, University of Toyama, 2630, Sugitani, Toyama-shi, Toyama 930-0194, Japan. hidaka@med.u-toyama.ac.jp</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Obstetrics and Gynecology, Faculty of Medicine, University of Toyama, 2630, Sugitani, Toyama-shi, Toyama 930-0194</wicri:regionArea><wicri:noRegion>Toyama 930-0194</wicri:noRegion></affiliation></author><author><name sortKey="Kato, K" sort="Kato, K" uniqKey="Kato K" first="K" last="Kato">K. Kato</name></author><author><name sortKey="Yonezawa, R" sort="Yonezawa, R" uniqKey="Yonezawa R" first="R" last="Yonezawa">R. Yonezawa</name></author><author><name sortKey="Shima, T" sort="Shima, T" uniqKey="Shima T" first="T" last="Shima">T. Shima</name></author><author><name sortKey="Nakashima, A" sort="Nakashima, A" uniqKey="Nakashima A" first="A" last="Nakashima">A. Nakashima</name></author><author><name sortKey="Nagira, K" sort="Nagira, K" uniqKey="Nagira K" first="K" last="Nagira">K. Nagira</name></author><author><name sortKey="Nakamura, T" sort="Nakamura, T" uniqKey="Nakamura T" first="T" last="Nakamura">T. Nakamura</name></author><author><name sortKey="Saito, S" sort="Saito, S" uniqKey="Saito S" first="S" last="Saito">S. Saito</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2007">2007</date><idno type="RBID">pubmed:17095180</idno><idno type="pmid">17095180</idno><idno type="doi">10.1016/j.ejso.2006.09.035</idno><idno type="wicri:Area/PubMed/Corpus">003829</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003829</idno><idno type="wicri:Area/PubMed/Curation">003829</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003829</idno><idno type="wicri:Area/PubMed/Checkpoint">003829</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003829</idno><idno type="wicri:Area/Ncbi/Merge">002476</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Omission of lymphadenectomy is possible for low-risk corpus cancer.</title><author><name sortKey="Hidaka, T" sort="Hidaka, T" uniqKey="Hidaka T" first="T" last="Hidaka">T. Hidaka</name><affiliation wicri:level="1"><nlm:affiliation>Department of Obstetrics and Gynecology, Faculty of Medicine, University of Toyama, 2630, Sugitani, Toyama-shi, Toyama 930-0194, Japan. hidaka@med.u-toyama.ac.jp</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Obstetrics and Gynecology, Faculty of Medicine, University of Toyama, 2630, Sugitani, Toyama-shi, Toyama 930-0194</wicri:regionArea><wicri:noRegion>Toyama 930-0194</wicri:noRegion></affiliation></author><author><name sortKey="Kato, K" sort="Kato, K" uniqKey="Kato K" first="K" last="Kato">K. Kato</name></author><author><name sortKey="Yonezawa, R" sort="Yonezawa, R" uniqKey="Yonezawa R" first="R" last="Yonezawa">R. Yonezawa</name></author><author><name sortKey="Shima, T" sort="Shima, T" uniqKey="Shima T" first="T" last="Shima">T. Shima</name></author><author><name sortKey="Nakashima, A" sort="Nakashima, A" uniqKey="Nakashima A" first="A" last="Nakashima">A. Nakashima</name></author><author><name sortKey="Nagira, K" sort="Nagira, K" uniqKey="Nagira K" first="K" last="Nagira">K. Nagira</name></author><author><name sortKey="Nakamura, T" sort="Nakamura, T" uniqKey="Nakamura T" first="T" last="Nakamura">T. Nakamura</name></author><author><name sortKey="Saito, S" sort="Saito, S" uniqKey="Saito S" first="S" last="Saito">S. Saito</name></author></analytic><series><title level="j">European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</title><idno type="ISSN">0748-7983</idno><imprint><date when="2007" type="published">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Carcinoma, Endometrioid (mortality)</term><term>Carcinoma, Endometrioid (pathology)</term><term>Carcinoma, Endometrioid (surgery)</term><term>Endometrial Neoplasms (mortality)</term><term>Endometrial Neoplasms (pathology)</term><term>Endometrial Neoplasms (surgery)</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymph Node Excision (contraindications)</term><term>Lymphatic Metastasis</term><term>Middle Aged</term><term>Neoplasm Staging</term><term>Prognosis</term><term>Retrospective Studies</term><term>Survival Rate</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Carcinome endométrioïde ()</term><term>Carcinome endométrioïde (anatomopathologie)</term><term>Carcinome endométrioïde (mortalité)</term><term>Femelle</term><term>Humains</term><term>Lymphadénectomie ()</term><term>Métastase lymphatique</term><term>Pronostic</term><term>Stade de la tumeur</term><term>Sujet âgé</term><term>Taux de survie</term><term>Tumeurs de l'endomètre ()</term><term>Tumeurs de l'endomètre (anatomopathologie)</term><term>Tumeurs de l'endomètre (mortalité)</term><term>Études de suivi</term><term>Études rétrospectives</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Carcinome endométrioïde</term><term>Tumeurs de l'endomètre</term></keywords><keywords scheme="MESH" qualifier="contraindications" xml:lang="en"><term>Lymph Node Excision</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Carcinoma, Endometrioid</term><term>Endometrial Neoplasms</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Carcinome endométrioïde</term><term>Tumeurs de l'endomètre</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Carcinoma, Endometrioid</term><term>Endometrial Neoplasms</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Carcinoma, Endometrioid</term><term>Endometrial Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymphatic Metastasis</term><term>Middle Aged</term><term>Neoplasm Staging</term><term>Prognosis</term><term>Retrospective Studies</term><term>Survival Rate</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Carcinome endométrioïde</term><term>Femelle</term><term>Humains</term><term>Lymphadénectomie</term><term>Métastase lymphatique</term><term>Pronostic</term><term>Stade de la tumeur</term><term>Sujet âgé</term><term>Taux de survie</term><term>Tumeurs de l'endomètre</term><term>Études de suivi</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The objective of this study is to ascertain whether omission of lymphadenectomy is possible when endometrial cancer is considered low-risk based on intraoperative pathologic indicators.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17095180</PMID><DateCreated><Year>2007</Year><Month>01</Month><Day>29</Day></DateCreated><DateCompleted><Year>2007</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2007</Year><Month>07</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0748-7983</ISSN><JournalIssue CitedMedium="Print"><Volume>33</Volume><Issue>1</Issue><PubDate><Year>2007</Year><Month>Feb</Month></PubDate></JournalIssue><Title>European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</Title><ISOAbbreviation>Eur J Surg Oncol</ISOAbbreviation></Journal><ArticleTitle>Omission of lymphadenectomy is possible for low-risk corpus cancer.</ArticleTitle><Pagination><MedlinePgn>86-90</MedlinePgn></Pagination><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">The objective of this study is to ascertain whether omission of lymphadenectomy is possible when endometrial cancer is considered low-risk based on intraoperative pathologic indicators.</AbstractText><AbstractText Label="PATIENT AND METHODS" NlmCategory="METHODS">A total of 128 patients were deemed to be low-risk based on intraoperative evaluation, including frozen-section determination of grade and myometrial invasion. We divided these 128 patients into 2 groups, the total abdominal hysterectomy and bilateral salpingo-oophorectomy (TAH-BSO) with lymphadenectomy (LA group, n=68) and the TAH-BSO without lymphadenectomy (non-LA group, n=60) group. The only adjuvant treatment used was chemotherapy, and the decision to use chemotherapy was based on stage, grade, or lymphovascular space involvement. A retrospective review of the medical records was performed, and disease-free survival (DFS), overall survival (OS), operative time, estimated blood loss during operation, percentage of transfusion requirement, incidence of post-operative leg lymphedema and post-operative deep vein thrombosis were evaluated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The 5-year DFS and OS rates were 95.6% and 98.5% in the LA group, and 98.3% and 98.3% in the non-LA group, respectively, and were not significantly different. In the LA group, pelvic lymph node metastasis was observed in only 1 case. In the LA group, blood loss during operation, percentage of transfusion requirement and the incidence of post-operative leg lymphedema were significantly higher than those in the non-LA group.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Lymphadenectomy did not provide a significant survival advantage in the patients with low-risk corpus cancer. Additionally, some peri- and post-operative morbidities and complications were increased by the addition of lymphadenectomy. The present findings suggest that lymphadenectomy should be limited for low-risk corpus cancer.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hidaka</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Faculty of Medicine, University of Toyama, 2630, Sugitani, Toyama-shi, Toyama 930-0194, Japan. hidaka@med.u-toyama.ac.jp</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kato</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Yonezawa</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Shima</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Nakashima</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Nagira</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Saito</LastName><ForeName>S</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2006</Year><Month>11</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Surg Oncol</MedlineTA><NlmUniqueID>8504356</NlmUniqueID><ISSNLinking>0748-7983</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018269" MajorTopicYN="N">Carcinoma, Endometrioid</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016889" MajorTopicYN="N">Endometrial Neoplasms</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000744" MajorTopicYN="Y">contraindications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2006</Year><Month>05</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2006</Year><Month>09</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>11</Month><Day>11</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>3</Month><Day>30</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>11</Month><Day>11</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17095180</ArticleId><ArticleId IdType="pii">S0748-7983(06)00365-9</ArticleId><ArticleId IdType="doi">10.1016/j.ejso.2006.09.035</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Japon</li></country></list><tree><noCountry><name sortKey="Kato, K" sort="Kato, K" uniqKey="Kato K" first="K" last="Kato">K. Kato</name><name sortKey="Nagira, K" sort="Nagira, K" uniqKey="Nagira K" first="K" last="Nagira">K. Nagira</name><name sortKey="Nakamura, T" sort="Nakamura, T" uniqKey="Nakamura T" first="T" last="Nakamura">T. Nakamura</name><name sortKey="Nakashima, A" sort="Nakashima, A" uniqKey="Nakashima A" first="A" last="Nakashima">A. Nakashima</name><name sortKey="Saito, S" sort="Saito, S" uniqKey="Saito S" first="S" last="Saito">S. Saito</name><name sortKey="Shima, T" sort="Shima, T" uniqKey="Shima T" first="T" last="Shima">T. Shima</name><name sortKey="Yonezawa, R" sort="Yonezawa, R" uniqKey="Yonezawa R" first="R" last="Yonezawa">R. Yonezawa</name></noCountry><country name="Japon"><noRegion><name sortKey="Hidaka, T" sort="Hidaka, T" uniqKey="Hidaka T" first="T" last="Hidaka">T. Hidaka</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002476 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 002476 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:17095180
|texte= Omission of lymphadenectomy is possible for low-risk corpus cancer.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:17095180" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |